Home > Category > Inhibitory Antibodies > Antibodies > Nivolumab (anti-PD-1) (Synonyms:BMS-936558; ONO-4538; MDX-1106)

纳武单抗 (anti-PD-1); 尼鲁单抗

ChemLeader 95+%

Catalog No：CLA1002 CAS No.：946414-94-4 MDLNo： Formula： MW： 143599.09

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	￥2000.00	Visible after login	- +
5 mg	3-5days	￥7500.00	Visible after login	- +
10 mg	3-5days	￥12000.00	Visible after login	- +
50 mg	3-5days	￥28000.00	Visible after login	- +
100 mg	3-5days	￥45600.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Nivolumab (anti-PD-1) (Synonyms:BMS-936558; ONO-4538; MDX-1106)
CAS	946414-94-4
MW	143599.09
Appearance	Colorless to light yellow liquid
Storage condition	Sealed and stored at ≤-80℃, away from light. Avoid freeze-thaw cycles

Product details

1.Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.

2.Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1002

Nivolumab (anti-PD-1) (Synonyms:BMS-936558; ONO-4538; MDX-1106)